136 related articles for article (PubMed ID: 38133738)
1. Association of metastatic pattern in breast cancer with tumor and patient-specific factors: a nationwide autopsy study using artificial intelligence.
Kazemzadeh F; Snoek JAA; Voorham QJ; van Oijen MGH; Hugen N; Nagtegaal ID
Breast Cancer; 2024 Mar; 31(2):263-271. PubMed ID: 38133738
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study.
Sihto H; Lundin J; Lundin M; Lehtimäki T; Ristimäki A; Holli K; Sailas L; Kataja V; Turpeenniemi-Hujanen T; Isola J; Heikkilä P; Joensuu H
Breast Cancer Res; 2011 Sep; 13(5):R87. PubMed ID: 21914172
[TBL] [Abstract][Full Text] [Related]
3. Metastatic progression of breast cancer: insights from 50 years of autopsies.
Cummings MC; Simpson PT; Reid LE; Jayanthan J; Skerman J; Song S; McCart Reed AE; Kutasovic JR; Morey AL; Marquart L; O'Rourke P; Lakhani SR
J Pathol; 2014 Jan; 232(1):23-31. PubMed ID: 24122263
[TBL] [Abstract][Full Text] [Related]
4. ER
Arciero CA; Guo Y; Jiang R; Behera M; O'Regan R; Peng L; Li X
Clin Breast Cancer; 2019 Aug; 19(4):236-245. PubMed ID: 30846407
[TBL] [Abstract][Full Text] [Related]
5. Organotropism and prognostic marker discordance in distant metastases of breast carcinoma: fact or fiction? A clinicopathologic analysis.
St Romain P; Madan R; Tawfik OW; Damjanov I; Fan F
Hum Pathol; 2012 Mar; 43(3):398-404. PubMed ID: 21840040
[TBL] [Abstract][Full Text] [Related]
6. New insights into patterns of first metastatic sites influencing survival of patients with hormone receptor-positive, HER2-negative breast cancer: a multicenter study of 271 patients.
Yamamura J; Kamigaki S; Fujita J; Osato H; Manabe H; Tanaka Y; Shinzaki W; Hashimoto Y; Komoike Y
BMC Cancer; 2021 Apr; 21(1):476. PubMed ID: 33926418
[TBL] [Abstract][Full Text] [Related]
7. Histologic heterogeneity predicts patient prognosis of HER2-positive metastatic breast cancer: A retrospective study based on SEER database.
Wang Y; Liang Y; Ye F; Luo D; Jin Y; Li Y; Zhao W; Chen B; Wang L; Yang Q
Cancer Med; 2023 Sep; 12(18):18597-18610. PubMed ID: 37605516
[TBL] [Abstract][Full Text] [Related]
8. Comparison of ER/PR and HER2 statuses in primary and paired liver metastatic sites of breast carcinoma in patients with or without treatment.
Liu J; Deng H; Jia W; Zeng Y; Rao N; Li S; Jin L; Wu J; Song E; Su F
J Cancer Res Clin Oncol; 2012 May; 138(5):837-42. PubMed ID: 22290394
[TBL] [Abstract][Full Text] [Related]
9. Impact of estrogen receptor (ER) and human epidermal growth factor receptor-2 (HER2) co-expression on breast cancer disease characteristics: implications for tumor biology and research.
Alqaisi A; Chen L; Romond E; Chambers M; Stevens M; Pasley G; Awasthi M; Massarweh S
Breast Cancer Res Treat; 2014 Nov; 148(2):437-44. PubMed ID: 25257728
[TBL] [Abstract][Full Text] [Related]
10. Patterns of relapse and metastatic spread in HER2-overexpressing breast cancer according to estrogen receptor status.
Park YH; Lee S; Cho EY; Choi YL; Lee JE; Nam SJ; Yang JH; Ahn JS; Im YH
Cancer Chemother Pharmacol; 2010 Aug; 66(3):507-16. PubMed ID: 19956951
[TBL] [Abstract][Full Text] [Related]
11. Specific sites of metastases in invasive lobular carcinoma: a retrospective cohort study of metastatic breast cancer.
Inoue M; Nakagomi H; Nakada H; Furuya K; Ikegame K; Watanabe H; Omata M; Oyama T
Breast Cancer; 2017 Sep; 24(5):667-672. PubMed ID: 28108967
[TBL] [Abstract][Full Text] [Related]
12. Profile and Outcome of Supraclavicular Metastases in Patients with Metastatic Breast Cancer: Discordance of Receptor Status Between Primary and Metastatic Site.
Thangarajah F; Vogel C; Pahmeyer C; Eichler C; Holtschmidt J; Ratiu D; Mallmann P; Malter W
Anticancer Res; 2018 Oct; 38(10):6023-6026. PubMed ID: 30275235
[TBL] [Abstract][Full Text] [Related]
13. Metastatic behavior and overall survival according to breast cancer subtypes in stage IV inflammatory breast cancer.
van Uden DJP; van Maaren MC; Strobbe LJA; Bult P; van der Hoeven JJ; Siesling S; de Wilt JHW; Blanken-Peeters CFJM
Breast Cancer Res; 2019 Oct; 21(1):113. PubMed ID: 31623649
[TBL] [Abstract][Full Text] [Related]
14. Metabolic activity of breast cancer metastatic lesions on positron emission tomography/computed tomography: comparison with histological and biological characteristics of primary tumor.
Sobic Saranovic D; Stojiljkovic M; Susnjar S; Odalovic S; Artiko V; Pavlovic S; Grozdic-Milojevic I; Obradovic V
Neoplasma; 2016; 63(2):313-21. PubMed ID: 26774154
[TBL] [Abstract][Full Text] [Related]
15. Comparison of immunophenotypes of primary breast carcinomas and multiple corresponding distant metastases: an autopsy study of 25 patients.
Szekely B; Nagy ZI; Farago Z; Kiss O; Lotz G; Kovacs KA; Madaras L; Udvarhelyi N; Dank M; Szentmartoni G; Baranyai Z; Harsanyi L; Tőkés AM; Timar J; Szasz AM; Kulka J
Clin Exp Metastasis; 2017 Jan; 34(1):103-113. PubMed ID: 27885435
[TBL] [Abstract][Full Text] [Related]
16. Population-based validation of the National Cancer Comprehensive Network recommendations for breast cancer staging.
Abdel-Rahman O
Breast Cancer Res Treat; 2018 Nov; 172(1):231-238. PubMed ID: 30022329
[TBL] [Abstract][Full Text] [Related]
17. Breast carcinoma subtypes show different patterns of metastatic behavior.
Molnár IA; Molnár BÁ; Vízkeleti L; Fekete K; Tamás J; Deák P; Szundi C; Székely B; Moldvay J; Vári-Kakas S; Szász MA; Ács B; Kulka J; Tőkés AM
Virchows Arch; 2017 Mar; 470(3):275-283. PubMed ID: 28101678
[TBL] [Abstract][Full Text] [Related]
18. Metastatic pattern in colorectal cancer is strongly influenced by histological subtype.
Hugen N; van de Velde CJH; de Wilt JHW; Nagtegaal ID
Ann Oncol; 2014 Mar; 25(3):651-657. PubMed ID: 24504447
[TBL] [Abstract][Full Text] [Related]
19. Divergent Metastatic Patterns Between Subtypes of Thyroid Carcinoma Results From the Nationwide Dutch Pathology Registry.
Hugen N; Sloot YJE; Netea-Maier RT; van de Water C; Smit JWA; Nagtegaal ID; van Engen-van Grunsven ICH
J Clin Endocrinol Metab; 2020 Mar; 105(3):e299-306. PubMed ID: 31641763
[TBL] [Abstract][Full Text] [Related]
20. Metastatic Breast Cancer in Kenya: Presentation, Pathologic Characteristics, and Patterns-Findings From a Tertiary Cancer Center.
Ekpe E; Shaikh AJ; Shah J; Jacobson JS; Sayed S
J Glob Oncol; 2019 Jul; 5():1-11. PubMed ID: 31291138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
